Details for Patent: 5,665,727

Summary for Patent: 5,665,727

Title:	Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them
Abstract:	The compounds of formula I, I have been found to have excellent topical activity. They are thus indicated for use in the topical treatment of inflammatory and hyperpoliferative skin diseases and of cutaneous manifestations of immunologically-induced illnesses, such as psoriasis.
Inventor(s):	Maximilian Grassberger, Josef Gottfried Meingassner, Anton Stutz, Peter Stutz
Assignee:	Astellas Pharma Inc
Application Number:	US08/291,010
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 5,665,727

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,665,727

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Austria	29527	Nov 09, 1987
Germany	37 42 805.5	Dec 17, 1987

International Family Members for US Patent 5,665,727

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	400808
Austria	407957
Austria	A273988